The latest deployment further highlights the momentum around production AI-driven NavaX implementations, and showcases the platform’s readiness for complex, character-based languages.
Boston, Massachusetts, USA and Tokyo, Japan – January 21, 2026 – ArisGlobal, an AI-first technology company at the forefront of Life Sciences and creator of LifeSphere®, today announced that another major global pharmaceutical organization has gone live with LifeSphere® NavaX Advanced Intake, ArisGlobal’s AI-powered solution for automated case intake – this time in Japan.
The production deployment marks an important milestone in the expansion of NavaX into the Japanese market, where high case-processing costs make efficiency gains particularly impactful. The current implementation supports close to 60% of the company’s local case intake volume and establishes a strong foundation for future expansion.
The go-live leverages NavaX’s Japanese Dynamic Data Extraction (DDE) to automate intake of diverse documents and complex case content, including character-based formats, handwritten forms, and scientific tables or figures. The successful rollout demonstrates the maturity of NavaX’s multi-modal, multi-lingual AI capabilities and reflects ArisGlobal’s continued investment in delivering production-ready AI, enabling customers to move beyond pilots and proofs of concept to measurable operational value.
“This important implementation demonstrates the maturity of NavaX Advanced Intake for complex, character-based languages like Japanese,” said Steven Nuckols, Chief Commercial Officer at ArisGlobal. “This latest successful NavaX go-live further reinforces that our customers are not just experimenting with AI, but actively deploying it to drive efficiency and quality across real-world operations.”
ArisGlobal’s impressive momentum with LifeSphere NavaX – its consistent progress from innovation to live production across regions – reinforces the company’s leadership in AI-driven pharmacovigilance as well as Regulatory operations. Its latest achievements will be detailed at the company’s upcoming Breakthrough 2026 event (February 10–11, 2026) in Madrid, Spain.
About ArisGlobal
ArisGlobal is a leading life sciences technology company and provider of cloud-based software solutions for pharmacovigilance, regulatory affairs, quality management, and medical affairs. LifeSphere®, the company’s unified product platform, delivers a powerful combination of domain expertise, advanced technology, and analytics to help life sciences organizations transform compliance into a strategic advantage. ArisGlobal serves more than 300 customers globally, including many of the world’s top pharmaceutical, biotechnology, and medical device companies. For more information, visit www.arisglobal.com.
